# Strata Critical Medical, Inc.

> Clarifo company profile — qualitative business description generated from
> the company's filings. Financial statements, charts and ratios are
> available on Clarifo (https://www.clarifo.com/en/companies/Strata Critical Medical, Inc.).

## Overview

Strata Critical Medical, Inc. is a U.S.-based time-critical logistics and medical services company focused on the transplant ecosystem. Through its Trinity Medical Solutions and Keystone Perfusion Services brands, it provides air and ground organ transport, organ placement, surgical organ recovery, normothermic regional perfusion, and perfusion staffing and equipment support.

## Products & services

• Air transport of donor organs and related medical materials
• Ground logistics for organs, staff, and samples
• Organ placement and donor organ evaluation support
• Surgical organ recovery and normothermic regional perfusion
• Perfusion staffing and equipment for cardiac surgery centers

- **Transplant logistics** (45%) — Air and ground transport, scheduling, and chain-of-custody services for organ recovery and transplant.
- **Organ placement services** (15%) — Administrative support for evaluating donor organs and coordinating acceptance decisions.
- **Clinical transplant services** (25%) — Surgical organ recovery, normothermic regional perfusion, and related clinical support.
- **Perfusion staffing and equipment** (15%) — Staffing and equipment solutions for cardiovascular surgery centers and hospitals.

- Air transport of donor organs and related medical materials
- Ground logistics for organs, staff, and samples
- Organ placement and donor organ evaluation support
- Surgical organ recovery and normothermic regional perfusion
- Perfusion staffing and equipment for cardiac surgery centers

## Customers

Strata sells directly to transplant centers, organ procurement organizations, hospitals, and other healthcare businesses that need time-sensitive transplant logistics or clinical support. Its services are used when organ offers, recovery, transport, and perfusion must be coordinated quickly and reliably, often under urgent clinical timelines.

- **Transplant centers** (primary) — Buy organ transport, placement, recovery, and NRP services to increase transplant throughput and reduce coordination burden.
- **Organ Procurement Organizations (OPOs)** (primary) — Use surgical recovery, preservation, and logistics services to manage donor organ recovery and delivery.
- **Hospitals and health systems** (secondary) — Purchase perfusion staffing, equipment, and related clinical support for cardiac surgery and transplant cases.
- **Cardiovascular surgery centers** (secondary) — Buy perfusion personnel and equipment on a contractual basis for operating-room support.

- Transplant centers that need organ transport and recovery support
- Organ procurement organizations that coordinate donor organ recovery
- Hospitals using perfusion staffing and equipment services
- Cardiovascular surgery centers needing perfusion coverage
- Customers buy for speed, reliability, compliance, and end-to-end coordination

## Geography

Strata’s business is concentrated in the United States, where it operates a nationwide network for transplant logistics and surgical services. Its air and ground operations span many locations across the country, which matters because organ transport is highly time-sensitive and depends on aircraft availability, routing, and local clinical resources.

- **United States** (100%) — Company describes its business as serving the U.S. healthcare industry nationwide.

- United States is the core market for all services
- Nationwide network supports urgent organ transport and recovery
- Operations depend on aircraft access across many U.S. locations
- Local clinical resources help reduce incremental logistics costs
- Geography matters because transplant cases are time-critical

## Strategy

Strata’s strategy is to offer an integrated “one call” solution that combines logistics and clinical services around transplant cases. It also aims to broaden use of its network by adding adjacent services such as organ placement, NRP, and perfusion staffing, which deepen customer relationships and increase the value of each case.

- **Integrated transplant platform** (medium-term) — Combining transport, recovery, placement, and perfusion improves customer convenience and differentiation.
- **Service expansion around transplant workflows** (medium-term) — Adjacent services increase share of wallet and make the company more embedded in the transplant ecosystem.
- **Technology-enabled execution** (short-term) — Software and tracking tools support reliability, compliance, and coordination in time-sensitive cases.

- Bundle logistics and clinical services into one coordinated offering
- Expand services around transplant cases to increase customer stickiness
- Use technology for staffing, training, and chain-of-custody tracking
- Support more organ offers and faster case coordination through TOPS
- Leverage local resources to reduce transport complexity and cost

## Risks

Strata depends on winning and retaining medical customers in a highly competitive, time-critical market where service reliability and pricing are central. Its business is also exposed to operational, reputational, technology, and clinical-liability risks because failures in transport, staffing, or data systems can directly disrupt transplant and surgical workflows.

- **Customer concentration and retention in transplant logistics** [high] — Revenue depends on securing medical customers and expanding services with existing accounts.
- **Operational failure in time-critical transport** [high] — Organ cases require rapid dispatch, aircraft availability, and precise coordination.
- **Technology and cybersecurity disruption** [high] — Logistics coordination, data tracking, and customer interfaces are essential to service delivery.
- **Clinical liability and reputational damage** [high] — Surgical recovery, perfusion, and NRP services can lead to claims, investigations, or negative publicity.
- **Competition from bundled device and logistics providers** [medium] — Organ preservation equipment makers may also offer transport and clinical services.

- Competition from internal hospital/OPO resources and specialty firms
- Reliability risk in urgent organ transport and clinical case execution
- Technology outages can disrupt logistics coordination and customer trust
- Clinical services create reputational, litigation, and liability exposure
- Customer demand for bundled services may favor competitors with broader offerings

## Accounting

Key accounting judgments include revenue recognition across per-case, retainer, and contractual service arrangements, which can affect timing and comparability between periods. Investors should also watch estimates tied to stock-based compensation, contingent consideration, and any impairment or valuation judgments related to acquisitions and intangible assets.

- **Revenue recognition by contract type** — Timing and quarterly comparability
- **Business combinations and contingent consideration** — Purchase accounting, liabilities, and earnings volatility
- **Stock-based compensation** — Non-cash expense and dilution
- **Goodwill and intangible asset impairment** — Potential non-cash write-downs

- Per-case and retainer contracts affect revenue timing and mix
- Clinical and logistics services may be recognized differently by contract type
- Stock-based compensation depends on multi-year performance targets
- Contingent consideration and business combinations require fair value estimates
- Acquired intangibles and goodwill may require impairment testing

---

*Last updated: 2026-04-29T05:00:27.459560+00:00*
